Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer

被引：0
|
作者：
Sophie Broutin
Adam Stewart
Parames Thavasu
Angelo Paci
Jean-Michel Bidart
Udai Banerji
机构：
[1] Gustave Roussy,Département de Biologie et Pathologie Médicales
[2] Université Paris-Saclay,undefined
[3] Villejuif,undefined
[4] F-94805,undefined
[5] France,undefined
[6] The Institute of Cancer Research,undefined
[7] Clinical Pharmacology and Trials Team,undefined
来源：
British Journal of Cancer | 2016年 / 115卷
关键词：
drug combinations; NSCLC; KRAS mutant; MEK inhibitor; trametinib; m-TOR inhibitor; AZD2014;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：549 / 552
页数：3
相关论文
共 50 条
  • [1] Insights into significance of combined inhibition of MEK and m-TOR signalling output in KRAS mutant non-small-cell lung cancer
    Broutin, Sophie
    Stewart, Adam
    Thavasu, Parames
    Paci, Angelo
    Bidart, Jean-Michel
    Banerji, Udai
    BRITISH JOURNAL OF CANCER, 2016, 115 (05) : 549 - 552
  • [2] Combined inhibition of MDM2 and MEK for KRAS mutant non-small cell lung cancer
    Hata, Aaron N.
    Archibald, Hannah L.
    Gomez-Caraballo, Maria D.
    DeBussche, Laurent R.
    Sidhu, Sukhvinder
    Watters, James
    Engelman, Jeffrey A.
    CANCER RESEARCH, 2014, 74 (19)
  • [3] Efficacy of immunotherapy in KRAS-mutant non-small-cell lung cancer with comutations
    Davis, Alexander P.
    Cooper, Wendy A.
    Boyer, Michael
    Lee, Jenny H.
    Pavlakis, Nick
    Kao, Steven C.
    IMMUNOTHERAPY, 2021, 13 (11) : 941 - 952
  • [4] Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future
    Uras, Iris Z.
    Moll, Herwig P.
    Casanova, Emilio
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) : 1 - 30
  • [5] Predictive Significance of KRAS and Tau for Chemoresponse in Advanced Non-Small-Cell Lung Cancer
    Yoo, Jinyoung
    Shim, Byoung Yong
    Yoo, Chang Young
    Kang, Seok Jin
    Lee, Kyo Young
    KOREAN JOURNAL OF PATHOLOGY, 2009, 43 (05) : 435 - 440
  • [6] Insights into EGFR Mutations and Oncogenic KRAS Mutations in Non-Small-Cell Lung Cancer
    Rosell, Rafael
    Aguilar-Hernandez, Andres
    Gonzalez-Cao, Maria
    CANCERS, 2023, 15 (09)
  • [7] Targeting Oncogenic KRAS in Non-Small-Cell Lung Cancer
    Sunaga, Noriaki
    Miura, Yosuke
    Kasahara, Norimitsu
    Sakurai, Reiko
    CANCERS, 2021, 13 (23)
  • [8] Inhibition of non-small-cell lung cancer growth by combined fulvestrant and vandetanib
    Klinge, Carolyn M.
    FUTURE ONCOLOGY, 2012, 8 (05) : 529 - 533
  • [9] Combined inhibition of ACK1 and AKT shows potential toward targeted therapy against KRAS-mutant non-small-cell lung cancer
    Yu, Xiangjing
    Liu, Jie
    Qiu, Huawei
    Hao, Huiting
    Zhu, Jinhong
    Peng, Shiyun
    BOSNIAN JOURNAL OF BASIC MEDICAL SCIENCES, 2021, 21 (02) : 198 - 207
  • [10] MEK inhibition in non-small cell lung cancer
    Stinchcombe, Thomas E.
    Johnson, Gary L.
    LUNG CANCER, 2014, 86 (02) : 121 - 125
12345